Safety in a Nutshell

Safety forms were approved on October 3, 2013 by Evan Appleton, member of the iGEM Safety Committee .

Synthetic Biology is without doubt a field in which a series of ethical and safety related questions arise. There is a generalized concern for the use of GMOs on applications like food and health.Thus, it is necessary for anyone working with GMOs to consider this kind of issues. Our team is no exception, the iGEM organization asks a set of questions related to the safety features of every team's project. These questions comprise the safety of the three main stakeholders: researchers, public, and environment. Given that our project involves the interaction of the GMOs with the human body at a certain extent, we carried out a thorough research of the safety related issues that our contrast agent could have on the patient and the environment. Aware that the general public might be reluctant to the idea of using bacteria within the human body for the visualization of tumors, we are currently working on a facts checking project. By doing these fact checks we aim to prove some of the most common beliefs related to synthetic biology and GMO's, as well as their use within the food and health industry, focusing mainly in those directly associated to our contrast agent. For further information of the fact check project checkout the human practices component of our wiki.

TU-Eindhoven Images publicSafety.jpg

We divided our safety page into three main sections:

The first section focuses, as the name indicates, on safety issues within the lab. We consider the protocols and regulations of lab work at the TU/e that concern the safety of the researchers, as well as working with micro-organisms, our BioBricks and the biosafety group.

The second section addresses the issues related to the misuse of our contrast agent and patient safety. Given the fact that our product is intended to be used within the human body, we make a great emphasis on patient safety.

Last but not least are our proposals for improving the biosafety and its awareness within the iGEM teams.